Fake pharma value surpassed €4.3bn, EUIPO report finds
The value of worldwide counterfeit pharmaceuticals surpassed €4.3bn during 2014-2016, according to a new report from the EU
Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD).
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.